List of Excipients in API phentermine and topiramate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing phentermine and topiramate
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Vivus Inc | QSYMIA | phentermine and topiramate | 62541-201 | CELLULOSE, MICROCRYSTALLINE | |
Vivus Inc | QSYMIA | phentermine and topiramate | 62541-201 | ETHYLCELLULOSE | |
Vivus Inc | QSYMIA | phentermine and topiramate | 62541-201 | FD&C BLUE NO. 1 | |
Vivus Inc | QSYMIA | phentermine and topiramate | 62541-201 | FD&C RED NO. 3 | |
Vivus Inc | QSYMIA | phentermine and topiramate | 62541-201 | GELATIN | |
Vivus Inc | QSYMIA | phentermine and topiramate | 62541-201 | POVIDONE K30 | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for phentermine and topiramate
Excipient focus: CELLULOSE, MICROCRYSTALLINE
phentermine and topiramate drug variants containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
Vivus Inc | phentermine and topiramate | 62541-201 |
Vivus LLC | phentermine and topiramate | 62541-202 |
>Company | >Ingredient | >NDC |
phentermine and topiramate drug variants not containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: ETHYLCELLULOSE
phentermine and topiramate drug variants containing ETHYLCELLULOSE
Company | Ingredient | NDC |
---|---|---|
Vivus Inc | phentermine and topiramate | 62541-201 |
Vivus LLC | phentermine and topiramate | 62541-202 |
>Company | >Ingredient | >NDC |
phentermine and topiramate drug variants not containing ETHYLCELLULOSE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
phentermine and topiramate drug variants containing FD&C BLUE NO. 1
Company | Ingredient | NDC |
---|---|---|
Vivus Inc | phentermine and topiramate | 62541-201 |
Vivus LLC | phentermine and topiramate | 62541-202 |
>Company | >Ingredient | >NDC |
phentermine and topiramate drug variants not containing FD&C BLUE NO. 1
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 3
phentermine and topiramate drug variants containing FD&C RED NO. 3
Company | Ingredient | NDC |
---|---|---|
Vivus Inc | phentermine and topiramate | 62541-201 |
Vivus LLC | phentermine and topiramate | 62541-202 |
>Company | >Ingredient | >NDC |
phentermine and topiramate drug variants not containing FD&C RED NO. 3
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 5
phentermine and topiramate drug variants containing FD&C YELLOW NO. 5
Company | Ingredient | NDC |
---|---|---|
Vivus LLC | phentermine and topiramate | 62541-202 |
>Company | >Ingredient | >NDC |
phentermine and topiramate drug variants not containing FD&C YELLOW NO. 5
Company | Ingredient | NDC |
---|---|---|
Vivus Inc | phentermine and topiramate | 62541-201 |
>Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
phentermine and topiramate drug variants containing FD&C YELLOW NO. 6
Company | Ingredient | NDC |
---|---|---|
Vivus LLC | phentermine and topiramate | 62541-202 |
>Company | >Ingredient | >NDC |
phentermine and topiramate drug variants not containing FD&C YELLOW NO. 6
Company | Ingredient | NDC |
---|---|---|
Vivus Inc | phentermine and topiramate | 62541-201 |
>Company | >Ingredient | >NDC |
Excipient focus: GELATIN
phentermine and topiramate drug variants containing GELATIN
Company | Ingredient | NDC |
---|---|---|
Vivus Inc | phentermine and topiramate | 62541-201 |
Vivus LLC | phentermine and topiramate | 62541-202 |
>Company | >Ingredient | >NDC |
phentermine and topiramate drug variants not containing GELATIN
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K30
phentermine and topiramate drug variants containing POVIDONE K30
Company | Ingredient | NDC |
---|---|---|
Vivus Inc | phentermine and topiramate | 62541-201 |
Vivus LLC | phentermine and topiramate | 62541-202 |
>Company | >Ingredient | >NDC |
phentermine and topiramate drug variants not containing POVIDONE K30
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
phentermine and topiramate drug variants containing STARCH, CORN
Company | Ingredient | NDC |
---|---|---|
Vivus Inc | phentermine and topiramate | 62541-201 |
Vivus LLC | phentermine and topiramate | 62541-202 |
>Company | >Ingredient | >NDC |
phentermine and topiramate drug variants not containing STARCH, CORN
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SUCROSE
phentermine and topiramate drug variants containing SUCROSE
Company | Ingredient | NDC |
---|---|---|
Vivus Inc | phentermine and topiramate | 62541-201 |
Vivus LLC | phentermine and topiramate | 62541-202 |
>Company | >Ingredient | >NDC |
phentermine and topiramate drug variants not containing SUCROSE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TALC
phentermine and topiramate drug variants containing TALC
Company | Ingredient | NDC |
---|---|---|
Vivus Inc | phentermine and topiramate | 62541-201 |
Vivus LLC | phentermine and topiramate | 62541-202 |
>Company | >Ingredient | >NDC |
phentermine and topiramate drug variants not containing TALC
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
phentermine and topiramate drug variants containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Vivus Inc | phentermine and topiramate | 62541-201 |
Vivus LLC | phentermine and topiramate | 62541-202 |
>Company | >Ingredient | >NDC |
phentermine and topiramate drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.